chartexchange

Recross Cardio Announces the 25th Subject Treated in the Global PROTEA-PFO Clinical Program

PR Newswire | Oct 5, 2026 7:00 AM EDT

Milestone highlights growing multicenter experience with Recross Cardio's novel PFO Sealing System NEW YORK, Oct. 5, 2026 /PRNewswire/ -- Recross Cardio Inc., a structural heart company pioneering novel membrane-based technologies for lifelong septal management, today announced the...

Read original article